Bolt Biotherapeutics, Inc. (BOLT) is listed on NASDAQ in the Manufacturing sector. This page tracks real-time BOLT price, technical indicators including RSI, MACD, and the 52-week range, plus fundamentals, earnings history, and recent insider trading activity.
Technical Analysis
RSI (14) 33.6 Near Oversold
Market Cap $6.5M
Volume 36.5K
Fundamentals — 10-Q Q2 2026
Revenue $31,000
Net Income $-15.0M
EPS $-8.88
Operating Margin -51532.3%
Net Margin -48271.0%
P/E Ratio -0.4x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Nemec Sarah | Senior VP, Finance and PAO | Buy | 125 | $5.49 | $686 | 2025 Jun 6 |
| Quinn William P. | President, CEO and CFO | Buy | 125 | $5.49 | $686 | 2025 Jun 6 |
| Quinn William P. | President, CEO and CFO | Buy | 5,000 | $0.57 | $2,850 | 2024 Dec 16 |
| Nemec Sarah | Senior VP, Finance and PAO | Buy | 5,000 | $0.57 | $2,850 | 2024 Dec 16 |
| Quinn William P. | Chief Financial Officer | Buy | 11,829 | $0.95 | $11,233 | 2023 Dec 12 |
| Engleman Edgar | Director | Sell | 148,884 | $0.87 | $129,330 | 2023 Nov 30 |
| Engleman Edgar | Director | Sell | 1,943 | $0.90 | $1,749 | 2023 Nov 21 |
| Vivo Opportunity, LLC | 10% Owner | Sell | 3,400 | $0.90 | $3,060 | 2023 Nov 21 |
| Vivo Opportunity, LLC | 10% Owner | Sell | 86,054 | $0.93 | $79,933 | 2023 Nov 20 |
| Engleman Edgar | Director | Sell | 49,173 | $0.93 | $45,675 | 2023 Nov 20 |
| Novo Holdings A/S | 10% Owner | Sell | 800,000 | $2.00 | $1.6M | 2022 Jul 13 |
| Quinn William P. | Chief Financial Officer | Buy | 6,256 | $7.05 | $44,092 | 2021 Dec 8 |
| Perez Edith A. | Chief Medical Officer | Buy | 1,328 | $12.93 | $17,175 | 2021 Dec 6 |
| Novo Holdings A/S | 10% Owner | Buy | 400,000 | $20.00 | $8.0M | 2021 Feb 9 |
| Khanna Ashish Siri Ram | Director | Buy | 2,200 | $20.00 | $44,000 | 2021 Feb 9 |
| Quinn William P. | Chief Financial Officer | Buy | 1,200 | $20.00 | $24,000 | 2021 Feb 9 |
| Vivo Capital Fund VIII, L.P. | 10% Owner | Buy | 349,774 | $20.00 | $7.0M | 2021 Feb 9 |
| Schatzman Randall C | Chief Executive Officer | Buy | 1,500 | $20.00 | $30,000 | 2021 Feb 9 |
| Shah Mahendra | Director | Sell | 62 | $20.00 | $1,240 | 2021 Feb 9 |
| Healy James | Director | Buy | 450,000 | $20.00 | $9.0M | 2021 Feb 9 |
Other Pharmaceutical Stocks
Take BOLT further
- Browse Pharmaceutical Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put BOLT in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Bolt Biotherapeutics, Inc. next reports.
Set alerts on BOLT
Get notified when Bolt Biotherapeutics, Inc. hits your price targets or technical conditions are met.
Get Started Free